JP Patent

JP7784437B2 — クロロプレン系ブロック共重合体、ラテックス、ラテックス組成物、及びゴム組成物

Assigned to Denka Co Ltd · Expires 2025-12-11 · 0y expired

What this patent protects

Patent listed against paltusotine-hydrochloride.

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP7784437B2
Jurisdiction: JP
Classification: —
Expires: 2025-12-11
Drug substance claim: No
Drug product claim: No
Assignee: Denka Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.